Infant RSV immunity study
Part of Immune system & allergy, Lungs & breathing clinical trials.
Researchers want to study how infants naturally fight RSV infections. You and your baby may join if your baby is born in April, May, June, September, October, or November at BC Women's Hospital or a nearby hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a birthing parent with a baby born in April, May, June, September, October, or November
- You delivered or plan to deliver at BC Women's Hospital or a nearby local hospital
- Your baby does not have a severe pregnancy complication or chronic condition that makes them automatically eligible for RSV shots in British Columbia
- Your baby was not born very early (before 35 weeks of pregnancy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the RSVpreF vaccine given during pregnancy can help pass antibodies to the baby in women living with HIV. It may protect the infant from RSV, a common respiratory virus.
This study tests whether giving a special antibody medicine (called RSV-SMA) to babies aged 6–9 months can help prevent respiratory syncytial virus (RSV), a common virus that causes serious breathing problems in young children. Your baby would receive the medicine and be followed to see if it helps protect them.
This study looks at how well RSV vaccines or antibody shots protect babies from severe respiratory infections. If your baby is under 1 year old, lives in Connecticut, and gets sick with a respiratory infection, they may be able to join.
This trial tests two ways to protect babies from RSV: a vaccine given to pregnant women, and an antibody shot given to newborns. Both are already approved—this study checks if using them together works better than either alone.
This study looks at how well a maternal RSV vaccine (ABRYSVO) works by using health records of babies born in Scotland. It helps determine if vaccinating pregnant people can protect newborns from severe RSV disease.
This study asks parents in Queensland about their infant's RSV (respiratory syncytial virus) vaccination status and experiences. RSV is a common virus that can cause serious breathing problems in babies, and this research helps understand vaccination patterns.
Hear when a new Respiratory Synctial Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.